In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
La haute juridiction a examiné, vendredi 17 avril, un recours déposé notamment par l’association Anticor contre le décret du 11 février nommant l’ancienne ministre de l’action et des comptes à la tête ...
Recursion Pharmaceuticals insiders reported 5 transactions totaling $366,367.08. Activity included 2 stock sales and 1 tax payment, with 2 additional non-cash share movements. Updated 2h ago · Powered ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results